Vanda Pharmaceuticals Inc. License Agreements

11 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
EX-10.3: AMENDED AND RESTATED LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2006
License Agreement, dated January 13, 2022, by and among MSN Pharmaceuticals Inc., MSN Laboratories Private Limited, Impax Laboratories LLC and the registrant
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2022
CONFIDENTIAL TREATMENT REQUESTED LICENSE AGREEMENT
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2017
CONFIDENTIAL TREATMENT REQUESTED LICENSE AGREEMENT
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2017
TENTH AMENDMENT TO AMENDED AND RESTATED LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
2013
LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT by and between ELI LILLY AND COMPANY (an Indiana corporation) and VANDA PHARMACEUTICALS INC. (a Delaware corporation) Dated as...
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
IN
2012
NINTH AMENDMENT TO AMENDED AND RESTATED LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
2012
AMENDMENT TO AMENDED AND RESTATED LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
2010
EX-10.4: NDD-094 LICENSE AGREEMENT
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
NY
2006
EX-10.4: NDD-094 LICENSE AGREEMENT
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
NY
2006
EX-10.3: AMENDED AND RESTATED LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT
License Agreements
Vanda Pharmaceuticals Inc.
Biotechnology
DE
2006